MKC
65
2
WU
14
2
OMC
37
2
AES
43
2
EXC
67
3
MAS
63
3
BAX
57
3
FLS
38
-3
LYB
23
5
GWW
62
4
DOV
48
2
HD
46
2
GME
75
-2
EXPE
70
-2
IRM
49
-3
EW
34
-2
SWKS
58
2
BDX
35
2
WDC
64
-4
DG
50
-3
MKC
65
2
WU
14
2
OMC
37
2
AES
43
2
EXC
67
3
MAS
63
3
BAX
57
3
FLS
38
-3
LYB
23
5
GWW
62
4
DOV
48
2
HD
46
2
GME
75
-2
EXPE
70
-2
IRM
49
-3
EW
34
-2
SWKS
58
2
BDX
35
2
WDC
64
-4
DG
50
-3
Financhill
Back

Amicus Therapeutics Stock Predictions

Sleep well at night with 7 stellar stocks to buy and hold forever

Get the complete list FREE for a limited time.
Sell
34

FOLD
Amicus Therapeutics

Last Price:
$6.15
Seasonality Move:
18.85%

7 Day Trial

ALL ACCESS PASS

$ 7

7 Stocks to Buy and Hold Forever

The result is a select group of high-quality blue-chip stocks.

Amicus Therapeutics Stock Forecast

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 20.6% based on the past 17 years of stock performance.
  • Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%
  • Is Amicus Therapeutics Stock Undervalued?
    The current Amicus Therapeutics [FOLD] share price is $6.11. The Score for FOLD is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Amicus Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Amicus Therapeutics has on average historically risen by 20.6% based on the past 17 years of stock performance.

Amicus Therapeutics Stock Rating

Sell
34
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics overpriced?

  • Amicus Therapeutics has risen higher in 6 of those 17 years over the subsequent 52-week period, corresponding to a historical accuracy of 35.29%

Amicus Therapeutics Stock Price History

Is FOLD stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
amicusrx.com

52-Week Data

52-Week High:
12.65
52-Week Low:
5.81

Prediction Charts

Market Cap:
1.9B
Price in USD:
6.11
Volume:
3.4M
Beta:
0.98

Technical Analysis

SMA50:
6.65
SMA100:
7.96
SMA200:
9.28
52-Wk Change:
-39.2%

Stock Predictions

  • Is Amicus Therapeutics stock public?
    Yes, Amicus Therapeutics is a publicly traded company.
  • What is the Amicus Therapeutics stock quote today?
    The Amicus Therapeutics stock price is 6.11 USD today.
  • How to buy Amicus Therapeutics stock online?
    You can buy Amicus Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
May-21 6.52 6.34 6.58 6.24
May-22 6.30 6.26 6.35 6.20
May-23 6.15 6.22 6.27 6.12
May-27 6.32 6.24 6.38 6.18
May-28 6.27 6.10 6.33 6.10
May-29 6.13 6.21 6.37 6.05
May-30 6.18 6.07 6.20 6.03
Jun-2 6.09 6.16 6.20 6.06
Jun-3 6.15 6.26 6.36 6.11
Jun-4 6.24 6.10 6.32 6.09
Jun-5 6.10 5.96 6.12 5.90
Jun-6 6.03 6.16 6.19 6.00
Jun-9 6.19 6.03 6.20 6.02
Jun-10 6.09 6.11 6.22 6.05

Amicus Therapeutics Earnings

Amicus Therapeutics Earnings Report: Per Share Amicus Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Amicus Therapeutics Forecast Revenue Growth

Amicus Therapeutics Stock Analysis: Historical quarterly revenues per share for Amicus Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.09 per share, and an increase next year of $0.35 per share.

* Amicus Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.